ACAD Financials

Acadia Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$26.29

Market Cap

$4.45B

P/E Ratio

17.0

EPS

$1.55

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$957.80M

Gross Profit

Operating Income

Net Income

$226.45M

EPS (Diluted)

$1.36

Balance Sheet Highlights

Total Assets

$1.19B

Total Liabilities

$454.96M

Shareholders Equity

Cash & Equivalents

$319.59M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$157.72M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

59.0%

Operating Margin

0.1%

Net Margin

0.2%

ROE

0.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ACAD revenue?

ACAD's most recent quarterly revenue was $957.80M. Annual revenue can be calculated by summing the four most recent quarters.

Is ACAD profitable?

ACAD reported a profit of $226.45M in the most recent quarter. The net profit margin is 0.2%.

What is ACAD market cap?

ACAD has a market capitalization of $4.45B, making it a mid-cap stock.

Does ACAD have debt?

View ACAD's balance sheet for debt information.

What is ACAD cash flow?

Cash flow data is available in the full financial statements.